IP Library Assignment 048099/0832
Patent Assignment
Reel/Frame 048099/0832

Corrective Assignment to Correct the Tyographical Error in Third and Fifth Inventors Name. Previously Recorded at Reel: 047159 Frame: 0812. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2018-11-08 Pages: 6
Assignors
BIRKLE, STEPHANE
Executed: 2018-10-01
COCHONNEAU, DENIS
Executed: 2018-10-01
DORVILLIUS, MYLENE
Executed: 2018-10-01
LE DOUSSAL, JEAN-MARC
Executed: 2018-10-02
TERME, MICKAEL
Executed: 2018-10-01
Assignees
OGD2 PHARMA
3, CHEMIN DU PRESSOIR CHENAIE, NANTES, F-44100, FRANCE
UNIVERSITE DE NANTES
1, QUAI DE TOURVILLE, BP 13522, NANTES, F-44035, FRANCE
Covered Property (1)
Targeting O-Acetylated GD2 Ganglioside as a New Therapeutic and Diagnostic Strategy for Cancer Stem Cells Cancer
Application: 15/984,980 →
Publication: US 2019/0023808
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 15, 2018
From: BIRKLE, STEPHANE; COCHONNEAU, DENIS; DORVILLIUS, MYIENE; LE DOUSSAL, JEAN-MARC
To: OGD2 PHARMA; UNIVERSITE DE NANTES
Reel/Frame 047159/0812 →
Change of Name Jun 3, 2022
From: UNIVERSITÉ DE NANTES
To: NANTES UNIVERSITÉ
Reel/Frame 060882/0010 →